Evidence is mounting that spinal cord injured (SCI) persons may be at increased risk of pressure ulcers due to prolonged immobilization together with the injury-induced loss of sympathetic tone and decreased vascular resistance. With a view to developing a new method of preventing pressure ulcers, the objective of this study was to determine whether high voltage pulsed galvanic stimulation (HVPGS) could increase sacral transcutaneous oxygen tension (Ptc02) in SCI persons lying prone and supine. In experiment 1, HVPGS applied to the back at spinal level T6 led to a sustained, dose-related increase in sacral Ptc02 in 3 subjects lying prone. In experiment 2, carried out on 29 subjects lying supine on egg-crate mattresses, HVPGS (75 volts, 10 Hz) produced a 35% increase in sacral Ptc02, from a baseline level (Mean ± SD) of 49 ± 21 mmHg to 66 ± 18 mmHg after 30 minutes of stimulation (F = 39.4, p < .00001). In experi ment 3, simulated HVPGS was found to have no effect on sacral Ptc02 in 5 subjects lying supine. In experiment 4, HVPGS was repeated on 10 subjects and its effects found to be highly reproducible. It is hypothesized that HVPGS restores sympathetic tone and vascular resistance below the level of the spinal cord lesion, thereby increasing the perfusion pressure gradient in the capillary beds. Randomized controlled trials are now indicated to determine the efficacy of HVPGS for preventing pressure ulcers.
Introduction
Pressure ulcers occur in 28-85% of spinal cord injured (SCI) patients, often within a few days of injury, and tend to develop on the lower parts of the body, especially the sacrum, trochanters, and ischial tuberos ities.I-5 Prolonged external pressure, result ing in impaired capillary circulation, is considered the major causal factor and frequent repositioning the key to preven- tion.6-9 Although localized pressure may be a necessary factor, it is not sufficient to explain the unusual susceptibility of SCI persons to pressure ulcers. Intrinsic as well as extrinsic factors determine the formation of pressure ulcers. 10 The most important intrinsic factor is thought to be reduced sympathetic tone in the vascular bed below the level of the lesion, due to the interruption of spinal vasomotor pathways. 10 This defect in vascu lar control may interact synergistically with ischemia due to external pressure to in crease the risk of cellular damage and necrosis. The reduced blood supply of SCI patients below the level of injury11 may further compromise the tissue supply of 0z and other components carried by circulating blood. 1 2 Consistent with other data support ing this emerging view, 13,14 we have found that SCI persons have significantly lower transcutaneous oxygen tension (PtcOz) levels at the sacrum compared to able bodied controls, especially when lying sup ine; furthermore, SCI persons below the median supine PtcOe value were significantly more likely to have a pressure ulcer than those above the median, suggesting that Ptc02 may be a useful indicator of suscepti bility to pressure ulcers. 15 Bogie et al1n recently reported that spinal cord injured persons who were walking at discharge had significantly higher sacral PteOZ levels during their hospitalization than wheelchair dependent subjects. In an earlier prospect ive study on the development of pressure ulcers in SCI persons,4 we found a signific ant association between systolic blood pres sure at the time of admission to the hospital and the development of ulcers. The partial pressure of oxygen (Pa02) was also lower in SCI patients who developed ulcers. These findings of significantly reduced blood pressure and slightly lower Pa02 likewise suggest an increased susceptibility of the tissues to hypoperfusion and oxygen de livery, with resultant pressure ulcers.
Based on the above review of etiologic factors, pressure ulcers might be prevented, in theory, by increasing the patient's resist ance to pressure. Prevention efforts have mainly focused on ways of reducing external pressure through repositioning and the use of pressure-relieving devices. 17 -19 However, such efforts are only partially effective at best. Acute SCI patients often cannot be repositioned due to spinal or vasomotor instability, thereby virtually guaranteeing a pressure ulcer; moreover, the nursing staff are usually insufficient to turn all patients at risk with sufficient frequency. Pressure relieving mattresses and beds also tend to be expensive and few have been evaluated for efficacy. 2 1J, 2 1 In view of these limitations, it would be desirable to find a way of increas ing the SCI person's resistance to pressure ulcers. We hypothesize that electrical stimulation may help to prevent pressure ulcers by restoring sympathetic tone below the level of the lesion, thereby increasing the perfu sion pressure gradient in the capillary beds and enhancing tissue oxygenation. The ob jectives of this study were to determine the effect of HVPGS on sacral transcutaneous oxygen tension (Ptc02) levels in SCI subjects lying (a) prone (experiment 1) and (b) supine (experiment 2); to determine the effect on Ptc02 levels of simulated HVPGS (experiment 3); and to determine the repro ducibility of HVPGS (experiment 4).
Experimental methods and design

Subjects
The SCI subjects taking part in this study were volunteers, ages 18 years and older, recruited from inpatients of the Louisiana Rehabilitation Institute. Written informed consent was obtained from all participants and the study protocol was approved by Louisiana State University Medical Center's Institutional Review Board. All SCI sub jects who were asked to participate agreed to do so.
Definitions and measures
The diagnosis of SCI and the level of lesion were accepted as recorded by the attending physician in the patients' hospital charts. Subjects were classified diagnostically as either paraplegic (complete or incomplete) or quadriplegic (complete or incomplete).
Tissue oxygenation at the sacrum was measured using a transcutaneous oxygen tension (Ptc02) monitor (Model 811, Nova metrix Medical Systems, Wallingford, CT). The sacrum was selected for Ptc02 monitor ing since it is the site at greatest risk of pressure ulcer development. The Ptc02 monitor incorporates a modified Clark polarographic electrode. Oxygen tension is measured through the use of an incorpor ated heating system which maintains the temperature of the electrode and the site beneath it at a set point (44.5 0c) . Heating the site beneath the electrode facilitates the diffusion of oxygen from the underlying tissue to the skin surface. Ptc02 was studied because it can be measured continuously and noninvasively, and because at 44.5 0c, in infants, it reportedly indicates the state of oxygen supply and demand in the cutaneous and subcutaneous tissues.
-Ill In normal in fants and adults, Ptc02 correlates highly with arterial oxygen values. -1 1 .-1 2 Ptc02 values are reliable, continuous, noninvasive trend monitors of Pa02 in critically ill subjects. During circulatory problems, when Ptc02 values are compared to Pa02 values, changes in Ptc02 reflect trends in the sever ity of flow shock. 43 In local areas of reduced blood flow due to imposed pressure, Ptc02 is assumed to reflect changes in oxygen de livery and demand.
A high voltage pulsed galvanic stimulator (Model GVII, Medical Devices, St Paul, MN), was used for electrical stimulation. High voltage pulsed galvanic stimulation (HVPGS) is characterized by a twin-peak monophasic wave form with a fixed duration in the microsecond range (up to 200 f-ts) and a voltage normally above 100 voltS.44 By using a decreased pulse duration and an increased voltage, deeper tissues can be stimulated without producing tissue dam age. The waveform is a monopolar twin peak with an instantaneous rate of rise and a slope on the downside of each peak. The intrapulse interval is permanently fixed at 100 f-ts. The pulse duration is measured at one-half of the pulse height (ie 5 f-ts) and likewise cannot be modified by the opera tor. The frequency is adjustable with a range of 1-100 pulse pairs/second (Hz). The intensity of the output voltage is adjustible with a range of 0-350 volts. The amount of current is restricted to microamperes, with a range of 0-700 f-tA and a maximum charge per pulse of 3.5 microcoulombs (7 micro coulombs/pair) .
Skin offers considerable resistance (as high as 100,000 ohms) to the flow of electrical current. When a current of low voltage units (ie TENS) is passed through a circuit containing resistors, drops in voltage occur and energy is lost. A high-voltage device produces a spontaneous breakdown in skin resistance. Procacci et at45 noted that when a high voltage stimulus (100 volts) was passed through a circuit designed to mimic the skin's electrical circuit, the current tended to flow toward the path of the capacitor. Since little energy is wasted cros sing a capacitor, as compared to crossing a resistor, a greater amount of current density occurs beneath the skin and reaches the target tissues; in addition, since a minimal amount of high-voltage current passes across the resistor side of the circuit, less energy is lost and converted to heat. 32 What degree of skin irritation, if any, can be expected after prolonged treatment with HVPGS? In one study using HVPGS for 30 minutes at an intensity of 100 volts and a frequency of 80-82 Hz, no significant change in skin pH was found. 44 Since the pulse duration of HVPGS ranges up to 200 f-tS, the probability of stimulating the A-delta (pain and temperature) and C (pain) sensory axons is decreased, thus minimizing the subject's discomfort. 3 2
Data collection
The study was carried out on SCI subjects lying on egg-crate mattresses. The Ptc02 sensor was first calibrated in room air and a drop of contact gel free of air bubbles was applied to the oxygen sensor membrane.
With the subject lying prone, the areas for sensor placement and stimulation were thoroughly cleaned with alcohol. The sensor was applied to the skin at approximately the second sacral segment along the midline using a two-sided adhesive ring, thereby ensuring an airtight seal. Two electrodes and conductive sponges, measuring 4 cm in diameter, were used for administering electrical stimulation. Experiment 1 was carried out to deter mine whether HVPGS could increase sacral Ptc02 in subjects lying prone. Three subjects participated in this experiment; 2 were incomplete quadriplegics, one a complete paraplegic. Once the oxygen sensor equilib rated, a 5-minute baseline reading was taken. Electrical stimulation was applied with the active (ie negative) electrode at spinal level T6 and the dispersive electrode at L2. Ptc02 was recorded at 5-minute intervals during 60 minutes of stimulation, followed by a 20-minute observation period. This procedure was performed twice on each subject a few days apart. Parameters were first set at 50 volts and 10 Hz, and then at 75 volts and 10 Hz.
In experiment 2, 29 SCI subjects were administered HVPGS while lying supine. The active electrode was placed at spinal level T6 and the dispersive electrode at TI2. The subject was turned on his back and the oxygen sensor allowed to equilibrate. Within a few minutes of being activated, the displayed Ptc02 value decreased substan tially and slowly approached a stable level as Paraplegia 31 (1993) 311-319 the sacral area was warmed and local arterialization occurred. Twenty minutes were allowed for the sensor to stabilize. The monitor was considered equilibrated if, at the end of this time, Ptc02 remained con stant over a 4-minute interval. Ptc02 values were recorded at 2-minute intervals and the reading at 10 minutes was defined as the baseline value. The electrical stimulator was activated and Ptc02 levels were recorded at 2-minute intervals for 30 minutes. The stimulator was then switched off and Ptc02 readings were taken for a further 15 minutes. Subjects were carefully monitored during the experiment to ensure that the oxygen tension sensor was securely attached and functioning correctly. Statistical com parisons were made between the baseline Ptc02 measurement and the PtcOZ reading taken (a) after 30 minutes of HVPGS, and (b) at the end of the 15 minute poststimul ation period. Data were collected for each subject on: level of SCI, days since SCI, reported weight at the time of injury, smoking habits in the past month, blood pressure and pulse, as well as the site, number and grade of existing pressure ulcers. 46
Experiment 3 was carried out on 5 sub jects, all of whom had previously particip ated in experiment 2, to determine the effect of simulated HVPGS on sacral Ptc02 levels in subjects lying supine. The objective was to control for the effect of electrical stimulation as well as the possible placebo effect of the stimulator. The same pro cedures were used as in experiment 2: the stimulator electrodes were taped to the subject and Ptc02 levels were monitored for the same time intervals, but the stimulator was not activated.
In experiment 4, the procedures of experi ment 2 was repeated on 10 subjects to determine the reproducibility of HVPGS. Comparisons were made between (a) the two baseline values, (b) the two Ptc02 levels attained with HVPGS, and (c) percentage increases in Ptc02 levels following HVPGS.
The data were analyzed using repeated measures analysis of variance, followed by Newman-Keuls post-hoc tests to determine specific within-and between-group differ ences.47
Results
Experiment 1
HVPGS applied to the 3 SCI subjects lying prone led to a sustained, dose-related in crease in Ptc02 at the sacrum, the increase being more dramatic in the 2 subjects with baseline Ptc02 values at or below the lower end of the normal range of 60-100 mmHg ( Figure 1 represents subject I) . All three subjects exhibited increases in Ptc02 when HVPGS was increased from 50 volts to 75 volts. The largest increase in Ptc02 observed in any subject (at 75 volts) was 57% above baseline ( Fig I) ; moreover, in 2 of the 3 subjects there was no indication that Ptc02 had increased to the maximal extent during stimulation. For the 3 subjects, neither set of parameters (50 volts or 75 volts) caused a visible contraction of the back muscles, and none reported any type of discomfort with the procedure. One subject described a warming sensation in his back during HVPGS. It should be noted that stimulation at 100 volts was found to have no additional 
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incremental effect on Ptc02 levels above that achieved with 75 volts. Hence, subse quent experiments were performed using 75 volts.
Experiment 2
Twenty-nine SCI persons (26 males and 3 females) undergoing rehabilitation were re cruited for the study after obtaining their written informed consent. The character istics of the 29 SCI persons are shown in Table 1 .
The stimulator electrodes and Ptc02 sen sor were positioned as described above. Electrical stimulation (75 volts, 10 Hz) was administered for 30 minutes while subjects lay supine, after a IS-minute baseline period. This was followed by an observation period of 15 minutes (Fig 2) . Compared to the final baseline Ptc02 reading (Mean ± SD) of 49 ± 21 mmHg, the level attained at the end of the 30-minute period of HVPGS was 66 ± 18 mmHg-35% higher, a highly significant increase (F = 39.42, The same procedure as in experiment 2 was repeated on 5 subjects, including the attach ment of the sensor and HVPGS electrodes, but the stimulator was not activated. The results of simulated HVPGS on Ptc02 levels are also depicted in Figure 2 . It can be seen that no change occurred in mean Ptc02 levels throughout the course of the experi ment.
Experiment 4
Ten subjects were administered HVPGS on two separate occasions, in most instances within a few days of each other, to deter mine the reproducibility of the effects. The results were highly consistent; thus, when mean baseline Ptc02 levels, Ptc02 levels attained with HVPGS, and percentage increases in Ptc02 from baseline were compared with each other, no significant differences were observed (F = 0.21, p = 0.66, in all comparisons).
Discussion
In previous research, 1 5 we compared sacral Ptc02 levels in 21 SCI persons and 11 able bodied controls lying prone and supine. In the prone position, that of the controls (Mean ± SD) was 76 ± 13 mmHg compared to 65 ± 16 mmHg in the SCIs (p = 0.053). In the supine position, however, while the Ptc02 level of the controls remained vir tually unchanged at 74 ± 10 mmHg, that of the SCI persons quickly dropped to 49 ± 26 mmHg. Using these supine levels for able bodied controls as the standard for normality, the results obtained in the pres ent experiments support the hypothesis that HVPGS can reliably increase the sacral Ptc02 levels of SCI persons lying supine into the normal range. A dose-related increase in sacral Ptc02 levels was also observed (100 volts < 75 volts> 50 volts) in 3 SCI persons lying prone (experiment 1).
Since ischemic injury at the sacrum occurs in the supine position, the paramount issue is whether HVPGS can produce clinically significant increases in Plc02 in this position. Experiment 2 showed that sacral Plc02 levels of SCI persons lying supine could indeed be increased 35% from the baseline level of 49 ± 21 mmHg to 66 ± 18 mmHg. and hence into the normal range. To counter the charge that this effect could have occurred by chance or as a result of the placebo effect, experiment 3 was carried out to determine the effect of simulated HVPGS. As expected, PleD2 levels re mained virtually unchanged throughout the experiment. supporting the hypothesis that HVPGS can increase Ptc02 in SCI subjects lying prone or supine. A further study (experiment 4) carried out on 10 subjects. showed that the effects of HVPGS were highly reproducible. It remains to be determined whether HVPGS can increase and normalize Plc02 levels in SCI persons over prolonged periods, as would be necessary to prevent pressure ulcers, and whether prolonged stimulation has adverse effects. No instance of burning or skin irritation was reported or observed in our experiments. An interesting observation in our study was that Plc02 levels tended to remain high and signific antly above baseline for the duration of the 15 minute post stimulatory period, suggest ing that intermittent HVPGS could be used in long term clinical applications. This would serve to minimize the risk of adverse effects on the skin.
Spinal cord injury results in autonomic dysfunction involving varying degrees of sympathetic loss with unopposed para sympathetic activity . .) 8 Since the systemic vascular resistance is mainly a function of the sympathetic nervous system (SNS), the former drops to extremely low levels follow ing SCI, especially cervical cord injury.
Systolic pressures in the range of 90 mmHg are common, with mean diastolic pressures of about 60-70 mmHg, reflecting a massive decrease in systemic vascular resistance and generalized vasodilatation. 48 Quadriplegic persons also have significantly lower basal plasma norepinephrine and epinephrine levels than neurologically intact con trols.49•5o The mechanism by which HYPOS increases sacral Ptc02 levels in SCI awaits investigation. One possibility is that HYPOS activates the peripheral SNS below the level of the spinal cord lesion, thereby increasing the perfusion pressure gradient in the capillary beds and enhancing tissue oxygenation.
In conclusion, HYPOS can reliably in crease the typically low sacral Ptc02 levels of SCI persons into the normal range. Randomized controlled trials are now 
